GHS has delivered consistent growth. Revenue expanded from RM71.2 million in FY22 to RM93.1 million in FY25, translating into a four-year CAGR of about 9.4%. More importantly, profitability has improved, with gross profit margins rising from 16.1% in FY22 to 25.1% in FY25, driven by a larger contribution from in-house products, better supplier terms, and scale efficiencies from a wide SKU base. M+ Global Research projects a three-year earnings CAGR of 13.3%, with core PATMI expected to reach RM8.8–10.5 million, underpinned by organic growth and upcoming capacity expansion.